APREAprea Therapeutics, Inc.vs its industry peers
A metric-by-metric comparison of Aprea Therapeutics, Inc. against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| APREThis | $9M#6 | — | 0.2x#2 | — | — | 2.8%#5 | — | -32.8%#2 | — | — | -50.0%#3 | — |
| TOVX | $10M#2 | 0.2x#3 | 0.2x#1 | — | -100.0%#4 | 7.5%#4 | — | -42.1%#3 | -51.4%#1 | — | -45.0%#2 | — |
| PPCB | $37M#1 | 0.0x#1 | 3.7x#8 | — | — | -3136.6%#10 | — | -599.6%#9 | -533.3%#3 | — | — | — |
| KALA | $10M#4 | 0.0x#2 | 1.1x#5 | — | — | 29.9%#3 | — | -298.3%#7 | -69.9%#2 | — | — | — |
| AZTR | $10M#5 | 8.1x#4 | 1.3x#6 | — | -100.0%#4 | -22.2%#6 | — | -149.4%#4 | — | — | — | — |
| VTGN | $10M#3 | — | 0.4x#3 | 8.0x#3 | 161.1%#2 | -35.5%#8 | -5683.7%#3 | -284.7%#6 | -949.7%#4 | — | — | — |
| ALZN | $9M#7 | — | 1.5x#7 | — | — | -94.3%#9 | — | -151.2%#5 | — | — | -30.0%#1 | — |
| ENSC | $9M#9 | — | — | 1.7x#1 | -2.8%#3 | -27.4%#7 | -202.1%#1 | — | — | — | -78.8%#5 | — |
| XCUR | $9M#8 | — | 9.0x#9 | — | -100.0%#4 | 49.0%#2 | — | -506.2%#8 | — | — | -64.6%#4 | — |
| TRAW | $8M#10 | — | 0.7x#4 | 2.9x#2 | 1134.5%#1 | 105.5%#1 | -640.7%#2 | 79.2%#1 | — | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. This table timed out mid-build, so it covers part of the group; ranks are within the rows shown and it fills in shortly. Table built 2026-09-17.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice